Top of this page
Skip navigation, go straight to the content

UCB aspires to be the patient-centric global biopharmaceutical leader. With a unique combination of expertise in biology and chemistry, UCB is a global leader in the field focusing on severe diseases in two therapeutic areas - CNS and Immunology. UCB also has a selective presence in primary care.
UCB IT maximises a global framework for excellence in business operations with the customer intimacy required to use technology as a strategic advantage:
UCB has headquarters in Belgium and the IT department has main centers in Brussels (Anderlecht and Braine L’Alleud), Germany (Monheim), U.K. (Slough), U.S. (Atlanta) and India (Bangalore) as well as presence across the globe.